Archean Ebitda vs Operating Income Analysis

ACI Stock

713.15 0.70 0.1%

Archean Chemical financial indicator trend analysis is way more than just evaluating Archean Chemical Ind prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Archean Chemical Ind is a good investment. Please check the relationship between Archean Chemical Ebitda and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Archean Chemical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ebitda vs Operating Income

Ebitda vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Archean Chemical Ind Ebitda account and Operating Income. At this time, the significance of the direction appears to have strong relationship.

The correlation between Archean Chemical's Ebitda and Operating Income is 0.76. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Operating Income in the same time period over historical financial statements of Archean Chemical Industries, assuming nothing else is changed. The correlation between historical values of Archean Chemical's Ebitda and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Archean Chemical Industries are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Ebitda i.e., Archean Chemical's Ebitda and Operating Income go up and down completely randomly.

Correlation Coefficient

0.76

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ebitda

Operating Income

Operating Income is the amount of profit realized from Archean Chemical Ind operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Archean Chemical Industries is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Archean Chemical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Archean Chemical Ind current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Archean Chemical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Tax Provision is expected to grow to about 1.6 B, whereas Selling General Administrative is forecasted to decline to about 244.9 M.

	2021	2022	2023	2024 (projected)
Interest Expense	1.6B	969.6M	84.6M	80.4M
Depreciation And Amortization	668.6M	686.3M	703.4M	683.5M

Interest Expense Depreciation And Amortization

Archean Chemical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue
Total Assets		-0.91	-0.68	-0.83	0.91	0.94	-0.91	0.91	-0.76	0.52	0.88	-0.51	-0.77	0.92	0.9	0.88	-0.68	0.45	0.56	0.89	-0.85	0.98	-0.78	0.75	0.9	-0.93
Short Long Term Debt Total	-0.91		0.55	0.7	-0.98	-0.86	1.0	-0.97	0.77	-0.55	-0.84	0.37	0.64	-0.97	-0.73	-0.74	0.86	-0.57	-0.41	-0.99	0.97	-0.88	0.63	-0.76	-0.81	0.94
Other Current Liab	-0.68	0.55		0.91	-0.49	-0.76	0.55	-0.49	0.5	-0.38	-0.74	0.76	0.95	-0.55	-0.62	-0.88	0.08	0.07	-0.83	-0.48	0.35	-0.6	0.95	-0.36	-0.89	0.54
Total Current Liabilities	-0.83	0.7	0.91		-0.66	-0.85	0.7	-0.66	0.78	-0.5	-0.81	0.84	0.98	-0.68	-0.86	-0.92	0.26	-0.1	-0.72	-0.63	0.53	-0.77	0.98	-0.46	-0.97	0.71
Total Stockholder Equity	0.91	-0.98	-0.49	-0.66		0.87	-0.98	1.0	-0.76	0.55	0.83	-0.29	-0.6	0.99	0.75	0.73	-0.89	0.6	0.4	0.99	-0.98	0.88	-0.6	0.84	0.76	-0.98
Property Plant And Equipment Net	0.94	-0.86	-0.76	-0.85	0.87		-0.86	0.87	-0.69	0.37	0.81	-0.58	-0.85	0.88	0.89	0.96	-0.6	0.48	0.77	0.85	-0.79	0.93	-0.86	0.7	0.93	-0.91
Net Debt	-0.91	1.0	0.55	0.7	-0.98	-0.86		-0.97	0.78	-0.58	-0.85	0.37	0.64	-0.97	-0.73	-0.73	0.86	-0.54	-0.4	-0.99	0.97	-0.87	0.63	-0.77	-0.8	0.94
Retained Earnings	0.91	-0.97	-0.49	-0.66	1.0	0.87	-0.97		-0.76	0.59	0.84	-0.26	-0.59	1.0	0.76	0.72	-0.87	0.56	0.4	0.98	-0.97	0.87	-0.6	0.88	0.75	-0.99
Accounts Payable	-0.76	0.77	0.5	0.78	-0.76	-0.69	0.78	-0.76		-0.63	-0.7	0.56	0.66	-0.74	-0.79	-0.64	0.54	-0.33	-0.31	-0.74	0.72	-0.72	0.65	-0.55	-0.74	0.79
Cash	0.52	-0.55	-0.38	-0.5	0.55	0.37	-0.58	0.59	-0.63		0.81	-0.09	-0.37	0.63	0.37	0.29	-0.36	-0.26	-0.07	0.52	-0.48	0.35	-0.4	0.74	0.41	-0.56
Non Current Assets Total	0.88	-0.84	-0.74	-0.81	0.83	0.81	-0.85	0.84	-0.7	0.81		-0.43	-0.75	0.88	0.71	0.75	-0.54	0.06	0.42	0.8	-0.73	0.75	-0.77	0.82	0.82	-0.83
Non Currrent Assets Other	-0.51	0.37	0.76	0.84	-0.29	-0.58	0.37	-0.26	0.56	-0.09	-0.43		0.86	-0.27	-0.69	-0.73	-0.08	-0.03	-0.66	-0.28	0.19	-0.5	0.84	0.05	-0.79	0.31
Other Assets	-0.77	0.64	0.95	0.98	-0.6	-0.85	0.64	-0.59	0.66	-0.37	-0.75	0.86		-0.62	-0.8	-0.94	0.18	-0.09	-0.83	-0.57	0.46	-0.72	1.0	-0.39	-0.96	0.65
Cash And Short Term Investments	0.92	-0.97	-0.55	-0.68	0.99	0.88	-0.97	1.0	-0.74	0.63	0.88	-0.27	-0.62		0.74	0.74	-0.84	0.5	0.43	0.98	-0.95	0.86	-0.63	0.89	0.77	-0.98
Net Receivables	0.9	-0.73	-0.62	-0.86	0.75	0.89	-0.73	0.76	-0.79	0.37	0.71	-0.69	-0.8	0.74		0.87	-0.47	0.41	0.59	0.7	-0.67	0.91	-0.81	0.55	0.87	-0.8
Common Stock Shares Outstanding	0.88	-0.74	-0.88	-0.92	0.73	0.96	-0.73	0.72	-0.64	0.29	0.75	-0.73	-0.94	0.74	0.87		-0.38	0.34	0.87	0.7	-0.62	0.88	-0.94	0.52	0.97	-0.79
Non Current Liabilities Total	-0.68	0.86	0.08	0.26	-0.89	-0.6	0.86	-0.87	0.54	-0.36	-0.54	-0.08	0.18	-0.84	-0.47	-0.38		-0.76	-0.07	-0.91	0.95	-0.7	0.17	-0.72	-0.42	0.81
Inventory	0.45	-0.57	0.07	-0.1	0.6	0.48	-0.54	0.56	-0.33	-0.26	0.06	-0.03	-0.09	0.5	0.41	0.34	-0.76		0.26	0.62	-0.69	0.59	-0.06	0.26	0.29	-0.56
Other Current Assets	0.56	-0.41	-0.83	-0.72	0.4	0.77	-0.4	0.4	-0.31	-0.07	0.42	-0.66	-0.83	0.43	0.59	0.87	-0.07	0.26		0.39	-0.29	0.58	-0.83	0.23	0.76	-0.49
Other Stockholder Equity	0.89	-0.99	-0.48	-0.63	0.99	0.85	-0.99	0.98	-0.74	0.52	0.8	-0.28	-0.57	0.98	0.7	0.7	-0.91	0.62	0.39		-0.99	0.86	-0.57	0.8	0.75	-0.95
Total Liab	-0.85	0.97	0.35	0.53	-0.98	-0.79	0.97	-0.97	0.72	-0.48	-0.73	0.19	0.46	-0.95	-0.67	-0.62	0.95	-0.69	-0.29	-0.99		-0.84	0.45	-0.78	-0.67	0.93
Total Current Assets	0.98	-0.88	-0.6	-0.77	0.88	0.93	-0.87	0.87	-0.72	0.35	0.75	-0.5	-0.72	0.86	0.91	0.88	-0.7	0.59	0.58	0.86	-0.84		-0.72	0.65	0.87	-0.9
Short Term Debt	-0.78	0.63	0.95	0.98	-0.6	-0.86	0.63	-0.6	0.65	-0.4	-0.77	0.84	1.0	-0.63	-0.81	-0.94	0.17	-0.06	-0.83	-0.57	0.45	-0.72		-0.42	-0.95	0.65
Intangible Assets	0.75	-0.76	-0.36	-0.46	0.84	0.7	-0.77	0.88	-0.55	0.74	0.82	0.05	-0.39	0.89	0.55	0.52	-0.72	0.26	0.23	0.8	-0.78	0.65	-0.42		0.51	-0.86
Common Stock	0.9	-0.81	-0.89	-0.97	0.76	0.93	-0.8	0.75	-0.74	0.41	0.82	-0.79	-0.96	0.77	0.87	0.97	-0.42	0.29	0.76	0.75	-0.67	0.87	-0.95	0.51		-0.79
Current Deferred Revenue	-0.93	0.94	0.54	0.71	-0.98	-0.91	0.94	-0.99	0.79	-0.56	-0.83	0.31	0.65	-0.98	-0.8	-0.79	0.81	-0.56	-0.49	-0.95	0.93	-0.9	0.65	-0.86	-0.79

Click cells to compare fundamentals

Archean Chemical Account Relationship Matchups

Archean Chemical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.3B	14.3B	15.3B	17.6B	20.6B	17.1B
Short Long Term Debt Total	9.0B	9.1B	9.0B	693.9M	978.2M	929.3M
Other Current Liab	64.8M	165.1M	543.8M	411.4M	271.8M	297.4M
Total Current Liabilities	2.5B	1.8B	1.8B	1.7B	1.3B	1.7B
Total Stockholder Equity	59.9M	723.8M	2.6B	14.3B	17.0B	17.9B
Property Plant And Equipment Net	10.7B	10.6B	11.0B	11.5B	12.1B	11.8B
Net Debt	9.0B	8.9B	8.9B	634.1M	523.4M	497.2M
Retained Earnings	(1.7B)	(1.0B)	23.9M	4.7B	7.3B	7.7B
Accounts Payable	1.7B	1.1B	1.1B	955.6M	998.1M	951.0M
Cash	1.0M	143.6M	55.1M	59.7M	454.8M	477.6M
Non Current Assets Total	11.7B	11.3B	11.3B	11.8B	13.3B	13.0B
Non Currrent Assets Other	626.4M	600.0M	20K	114.8M	1.1B	1.1B
Cash And Short Term Investments	471.7M	555.3M	628.2M	2.6B	4.0B	4.2B
Net Receivables	444.6M	680.7M	1.5B	1.2B	1.6B	994.9M
Liabilities And Stockholders Equity	14.3B	14.3B	15.3B	17.6B	20.6B	17.1B
Non Current Liabilities Total	11.7B	11.8B	10.9B	1.5B	2.2B	2.1B
Inventory	988.2M	1.1B	1.2B	1.7B	1.3B	1.3B
Other Current Assets	944.4M	904.1M	665.2M	601.6M	472.9M	597.2M
Total Liab	14.2B	13.6B	12.7B	3.2B	3.5B	3.4B
Total Current Assets	2.6B	3.0B	4.0B	5.8B	7.3B	4.1B
Short Term Debt	127.6M	169.3M	89.1M	328.9M	72.4M	68.8M
Intangible Assets	1.2M	1.3M	1.8M	1.7M	21.2M	22.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Archean Stock

Balance Sheet is a snapshot of the financial position of Archean Chemical Ind at a specified time, usually calculated after every quarter, six months, or one year. Archean Chemical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Archean Chemical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Archean currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Archean Ebitda vs Operating Income Analysis

Ebitda vs Operating Income

Ebitda vs Operating Income Correlation Analysis

Correlation Coefficient

Ebitda

Operating Income

Archean Chemical fundamental ratios Correlations

Archean Chemical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Archean Chemical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Archean Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Retained Earnings	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Retained Earnings
Short Term Debt	+ 1.0	Other Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Other Stockholder Equity	+ 0.99	Total Stockholder Equity

Total Liab	- 0.99	Other Stockholder Equity
Current Deferred Revenue	- 0.99	Retained Earnings
Other Stockholder Equity	- 0.99	Net Debt
Other Stockholder Equity	- 0.99	Short Long Term Debt Total
Current Deferred Revenue	- 0.98	Cash And Short Term Investments
Current Deferred Revenue	- 0.98	Total Stockholder Equity